Varichem Pharmaceuticals

What Varichem Pharmaceuticals does

Varichem Pharmaceuticals (Pvt) Ltd is a Harare-headquartered, GMP-certified pharmaceutical manufacturer founded on July 1, 1985 by three University of Zimbabwe colleagues — pharmacist Tobias Dzangare, finance manager Celestine Gadzikwa, and operations lead Glory Zata — who bootstrapped the venture with seed capital from a brake-fluid and lubricants business. The company manufactures 178+ registered medicines across five core categories: tablets and capsules, hospital packs, topical creams and ointments, oral liquids and syrups, and over-the-counter products. Its manufacturing capability is anchored at the Gleneagles plant (completed 1992), with an in-house Quality Control Laboratory performing raw-material, API, and finished-product testing. Production is sold through a B2B order portal and a telesales team, alongside direct institutional and government tender processes. The company operates a multi-channel distribution model: a 'Find a Stockist' pharmacy/retail network within Zimbabwe, direct supply to hospitals, NGOs, and government health programs, and regional distributor partnerships spanning 7+ African countries including Malawi, Zambia, Botswana, Mozambique, and Tanzania. Customer segments span government health programs, pharmacies and clinics, hospitals and healthcare institutions, regional distributors, and end consumers. Pricing is quote-based and not publicly disclosed, with orders confirmed within one business day. Varichem's most strategically significant achievements are in regulated HIV therapeutics: in 2004 it became the first local Zimbabwean manufacturer of antiretrovirals (launching Stalanev, Zimbabwe's first triple-combination ARV, under a compulsory license), and in 2010 it secured WHO prequalification for Stalanev 30 and Varivar — making it the first indigenous pharmaceutical company in Southern Africa to meet that standard, thereby unlocking participation in international donor-funded procurement programs. The company has survived material shocks (a 1987 factory fire and COVID-19-era supply disruptions) and continues to operate as a privately held, founder-managed business with no disclosed institutional investors.

Name

Varichem Pharmaceuticals

Legal name

Varichem Pharmaceuticals (Pvt) Ltd

Website

https://varichem.co.zw

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

101–250 employees

Short description

Varichem Pharmaceuticals is a Harare-based, GMP-certified pharmaceutical manufacturer founded in 1985 that produces 178+ generic and ARV medicines, including WHO-prequalified antiretrovirals, serving government health programs, hospitals, pharmacies, NGOs, and distributors across 7+ African countries.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Tender & Government Supply Markets (HLAIABAM)

akta.pro secondary industries

Infectious Disease & Antimicrobials Pharmaceuticals (HLAIAAAG), Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

Keywords

• Generic pharmaceuticals
• Pharmaceutical manufacturing
• Antiretroviral drugs
• Essential medicines
• GMP-certified drugs

Headquarters

HQ city

Harare

HQ country

Zimbabwe

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Sale of 178+ registered medicines including antibiotics, pain relief, cardiovascular treatments, topical creams, oral liquids, and hospital packs. Revenue from both commercial/retail sales and institutional/government procurement.
2. Regulatory & Export Support Services: Assistance to partners in navigating regulatory approvals across African markets, documentation support for customs, MOHs, and donor programs
3. Regional Distribution: Export of pharmaceutical products to 7+ countries across Southern Africa through distributor networks

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels4 records

Core offering

Varichem Pharmaceuticals manufactures and distributes a portfolio of 178+ registered essential medicines — including antibiotics, ARVs, pain relief, cardiovascular treatments, topical creams, oral liquids, and OTC products — under GMP-compliant processes at its Harare facility. It produces branded products (Corilief, Ibucet, OraChlor, Flumed, Neutracid, Stalanev 30, Varivar) and supplies institutional/government buyers, pharmacies, NGOs, and regional distributors across 7+ African countries.

Product overview

Varichem Pharmaceuticals operates as an integrated pharmaceutical manufacturer offering a portfolio of 178+ registered medicines across five core product categories: Tablets & Capsules, Hospital Packs, Topical Creams & Ointments, Oral Liquids & Syrups, and Over-the-Counters (OTC). Named brands include Corilief, Ibucet, OraChlor, Flumed, and Neutracid/NeutraGel. The company also produces WHO-prequalified antiretrovirals including Stalanev 30 and Varivar. Services span pharmaceutical manufacturing, regulatory and export support, and quality control and assurance — delivered through a GMP-certified facility in Harare, Zimbabwe.

Differentiator

Problem solved

Functional benefit

Products and services

• Stalanev 30 WHO-prequalified triple-combination antiretroviral (ARV) medication for HIV/AIDS treatment, manufactured in Harare, Zimbabwe.
• Varivar WHO-prequalified antiretroviral (ARV) medication for HIV/AIDS treatment.
• Corilief Non-drowsy sinus pain and allergy relief medication.
• Ibucet Pain relief capsules for general pain and menstrual discomfort.
• OraChlor Oral antiseptic mouthwash for dental and oral hygiene.
• Flumed Cold and flu symptom relief medication.
• Neutracid & NeutraGel Antacid and gastric relief formulations.
• Pharmaceutical Manufacturing Production of tablets, capsules, liquids, and topical formulations under GMP-aligned processes at the Harare facility for commercial and institutional volumes.
• Regulatory & Export Support Market-entry support including registration documentation, customs and ministry coordination, and export-market readiness for African regulatory environments.
• Quality Control & Assurance In-house laboratory testing for raw materials, APIs, and finished products with quality assurance documentation.

Quantifiable outcome

• 178+ registered pharmaceutical products across 5 core categories
• +2 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Regional Distributors (Malawi, Zambia, Botswana, Mozambique)coreChannel Partner/ Reseller/ DistributorDistribution partnerships enabling market penetration across 7+ African countries. Varichem provides regulatory support and documentation assistance for customs, MOHs approvals, and export-market readiness.
• Healthcare Facilities (Lusaka to Maputo)coreOthersSupply partnerships with clinics and healthcare facilities across Southern Africa from Lusaka to Maputo. Varichem products including antiretroviral drugs distributed through these regional healthcare networks.
• International Donor ProgramscoreOthersWHO prequalification enables participation in international donor-funded procurement programs. Supply of essential medicines including ARVs through donor-funded health programs across Africa.
• Regional UniversitiesminorStrategic or Co-development PartnerCollaboration with regional universities to train next generation of formulation scientists. Skill transfer partnerships ensuring local talent remains at the helm of pharmaceutical manufacturing.
• Diaspora NetworksminorOthersEarly partnerships with diaspora networks to source key reagents and maintain supply chain continuity during periods of economic instability and foreign exchange controls.

Scale indicators7 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Aspen Pharmacare: Largest African pharmaceutical manufacturer headquartered in South Africa, producing generics, ARVs, and specialty therapeutics for African and global markets. Direct peer as a regionally rooted generic manufacturer with WHO-prequalified ARV portfolio and multi-country distribution.
• Strides Pharma: Indian generic manufacturer with growing Africa-focused business in ARVs and essential medicines, including WHO-prefinished products for donor procurement. Comparable business model targeting African tender and public-sector markets.
• Emcure Pharmaceuticals: Indian pharmaceutical company with WHO-prequalified ARVs and emerging African market presence. Comparable in generic manufacturing and donor-funded procurement channel exposure.
• Cosmos Pharmaceutical (Kenya): East African pharmaceutical manufacturer producing generics and OTC products for regional markets. Comparable as an African-rooted generic manufacturer serving pharmacy, hospital, and government channels across a multi-country footprint.
• Aurobindo Pharma: Indian generic pharmaceutical manufacturer with extensive WHO-prequalified ARV portfolio and major export business to African markets via donor-funded programs. Comparable in supply chain position (API-to-finished-dose generics) and African go-to-market.
• Hetero Labs: Indian pharmaceutical company and one of the world's largest producers of generic ARVs, with strong supply relationships into African donor-funded programs. Directly comparable to Varichem's ARV manufacturing focus and African public-sector exposure.
• Cipla: Indian multinational generic pharmaceutical manufacturer with one of the largest ARV businesses globally and deep penetration into African markets via tender and donor channels. Directly comparable to Varichem in ARV manufacturing for donor-funded procurement.
• Universal Corporation (Kenya): Kenyan pharmaceutical manufacturer producing generics and essential medicines for East and Central African markets. Comparable as a regional African generics manufacturer serving government, NGO, and pharmacy channels.
• Adcock Ingram: South African pharmaceutical manufacturer supplying generics, OTC, and consumer health products across Southern Africa. Comparable as a regionally rooted manufacturer serving hospital, pharmacy, and government channels across the same geographic footprint.

Broad incumbents

• Viatris (formerly Mylan): Global generic and specialty pharmaceutical major with a strong ARV franchise (including supply to PEPFAR) and broad African footprint. Comparable as a large-scale WHO-prequalified ARV supplier serving donor-funded African procurement.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/VarichemP
• Facebookfacebook.com/Varichem1
• LinkedInlinkedin.com/company/varichem-pharmaceuticals-pvt-ltd

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Varichem Pharmaceuticals